A Euphoria-Suppressing Opioid, Ketan Mehta, Founder & CEO, Tris Pharma
From BioTech Nation ... with Dr. Moira Gunn · · 15 min
This plays from the publisher's own server. We do not host a copy.
Description
This is the 2026 BioTech Nation "5" (https://www.biotechnation.com/jpm-2026-btn-5): Five Companies Ready to Make a Difference. We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco. Hear all 5 interviews at https://www.biotechnation.com/jpm-2026-btn-5
On this episode of BioTech Nation... Ever wonder what makes opioids so addictive? Moira speaks with Ketan Mehta, Founder and CEO of Tris Pharma, about opioid-induced euphoria...and an opioid that's actually meant to suppress this response.
For more information about BioTech Nation and the companies featured here, visit: TechNation.com (https://technation.com/)
Back to BioTech Nation ... with Dr. Moira Gunn · Report a problem